Rui Wang - Concepedia

Author

Rui Wang

Fudan University Shanghai Cancer Center ORCID

Also Known As

Rui WANG, Rui Wang, Wang R, Wang Rui

137

Publications

Citations

H-Index

Concepts

All Affiliations

Fudan University Shanghai Cancer Center Shanghai Medical College of Fudan University Fudan University Shanghai Jiao Tong University Shanghai Chest Hospital

About

Rui Wang is an author at Fudan University Shanghai Cancer Center specializing in medicine, lung cancer, and oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	15	17	971
2	Cell Biology	4	4	241
3	Public Health	1	1	29
4	Diabetes	1	1	21
5	Immunology	1	1	58

Rui Wang

Publications

2.8K

Citations

H-Index

Page 1

	Year	Citations
<i>RET</i> Fusions Define a Unique Molecular and Clinicopathologic Subtype of Non–Small-Cell Lung Cancer Rui Wang, Haichuan Hu, Yunjian Pan, Journal of Clinical Oncology	2012	543
ALK, ROS1 and RET fusions in 1139 lung adenocarcinomas: A comprehensive study of common and fusion pattern-specific clinicopathologic, histologic and cytologic features Yunjian Pan, Yang Zhang, Yuan Li, Lung Cancer Cytologic FeaturesTumor BiologyMedicinePathologyBronchial Neoplasm	2014	217
Frequency of Driver Mutations in Lung Adenocarcinoma from Female Never-Smokers Varies with Histologic Subtypes and Age at Diagnosis Yang Zhang, Yihua Sun, Yunjian Pan, Clinical Cancer Research	2012	169
PIK3CA Mutations Frequently Coexist with EGFR/KRAS Mutations in Non-Small Cell Lung Cancer and Suggest Poor Prognosis in EGFR/KRAS Wildtype Subgroup Lei Wang, Haichuan Hu, Yunjian Pan, PLoS ONE	2014	162
Cancer-associated fibroblasts treated with cisplatin facilitates chemoresistance of lung adenocarcinoma through IL-11/IL-11R/STAT3 signaling pathway Leilei Tao, Guichun Huang, Rui Wang, Scientific Reports	2016	124
Frequency of well-identified oncogenic driver mutations in lung adenocarcinoma of smokers varies with histological subtypes and graduated smoking dose Hang Li, Yunjian Pan, Yuan Li, Lung Cancer Tobacco ControlSmoking DoseSmokers VariesMedicineGenetics	2012	104
Osimertinib as neoadjuvant therapy in patients with EGFR-mutant resectable stage II-IIIB lung adenocarcinoma (NEOS): A multicenter, single-arm, open-label phase 2b trial Chao Lv, Wentao Fang, Nan Wu, Lung Cancer	2023	101
A Comprehensive Investigation of Molecular Features and Prognosis of Lung Adenocarcinoma with Micropapillary Component Yang Zhang, Rui Wang, Deng Cai, Journal of Thoracic Oncology Multiple Pulmonary NoduleLung AdenocarcinomaMicropapillary ComponentPathologyBronchial Neoplasm	2014	94
Lung Adenocarcinomas with HER2-Activating Mutations Are Associated with Distinct Clinical Features and HER2/EGFR Copy Number Gains Chenguang Li, Yihua Sun, Rong Fang, Journal of Thoracic Oncology OncologyMedicinePathologyCancer GenomicsBronchial Neoplasm	2011	93
The Use of Quantitative Real-Time Reverse Transcriptase PCR for 5′ and 3′ Portions of <i>ALK</i> Transcripts to Detect <i>ALK</i> Rearrangements in Lung Cancers Rui Wang, Yunjian Pan, Chenguang Li, Clinical Cancer Research	2012	86

Page 1